Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New lung scan tested on sick kids

NCT ID NCT07532811

Knowledge-focused Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a special imaging technique called electrical impedance tomography (EIT) can safely measure blood flow and air distribution in the lungs of children with acute respiratory failure. Twenty children under 12 who are on breathing machines will receive a small injection of salt water during EIT monitoring. The goal is to see if this method works and is safe for children.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
sodium chloride or sodium bicarbonate injection
What this could lead to
If successful, this could lead to a safer way to monitor lung function in critically ill children.
What could go wrong
This is a very small, early pilot study with only 20 children. The method may not work well or could cause side effects like high sodium levels.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 20 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

Aug 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Up to 12 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * patients \< 12 years hospitalized in pediatric intensive care * intubated, under conventional invasive mechanical ventilation and sedated * between 3 and 40 kg * with central venous access in the superior vena cava * consent signed by parents or legal guardians Exclusion Criteria: * Patients with significant leaks \> 20% around the endotracheal tube * Patients receiving spontaneous ventilation (inspiratory support, NIV, etc.) * Natremia \> 150 mmol/L at inclusion * Hyperchloremia ≥ 115 mmol/L and/or hypokaliema ≤ 3 mmol/L * Patients with intracranial hypertension * Patients with active bleeding or persistent hemodynamic instability despite amines * Patients with heart failure, uncorrected cyanotic heart disease, or a history of cardiac arrhythmia * Patients with contraindications to the use of the electrical impedance pulmonary tomography belt (skin lesions, burns, or recent thoracic surgery) * Conditions in which EIT data acquisition will be disrupted (chest dressings, pneumothorax, ECMO) * Patients with severe hypoxemia defined as FiO2 \> 90% to maintain SpO2 \> 88% * Individuals not affiliated with a social security system or beneficiaries of a similar system

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute respiratory failure are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acute respiratory failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute respiratory failure

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Florent BAUDIN

    RECRUITING

    Bron, France, 69500, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.